Acumen Pharmaceuticals Inc

Sector: 
Professional, Scientific, and Technical Services
   

Industry: 
Research and Development in Biotechnology

4.88
 
USD
  
0.49
  
(11.16%)
Optionable: No  Market Cap: 178 M  90-day average vol: 238,402

Previous close: 4.39  Open: 4.4  Bid: 4.94  Ask: 4.94
52 week range    
3.02   
   26.98
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 30th June 2022
Search for a stock
Are you?
twitterstocktwits
Chart
Financials

ABOS Income Statement

Annual

Dec-19Dec-20Dec-21
Total revenues2 M00
Cost of sales00-159000
Gross operating profit2 M00
Selling Gen & administrative expense926000-850007 M
Research & development expense9 M8 M12 M
Operating income-8 M-8 M-20 M
floaterest income000
floaterest expense000
Other income net-147000586000-81 M
Pre-tax Income (EBT)-8 M-7 M-101 M
Income taxes000
Net income from total operations-8 M-7 M-101 M
Minority floaterest000
Total net income-8 M-7 M-101 M
Preferred dividendsN/AN/AN/A
Net income available for common-8 M-7 M-101 M
Depreciation00159000
Amortization000
Operating income before depreciation (EBITDA)-8 M-8 M-20 M
Total Income available for floaterest expense (EBIT)000
Basic EPS total-0.27-0.28-5.02
Diluted EPS total-0.27-0.28-5.02
Top MarketXLS Rank stocks

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!